(Q37233774)

19 August 2017

1 reference

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Immunosuppressive networks in the tumour environment and their effect in dendritic cells (English)

1 reference

19 August 2017

1 reference

3

Jean-Louis Touraine

1 reference

19 August 2017

Karim Bennaceur

1

1 reference

19 August 2017

Jessica Alice Chapman

series ordinal

2

1 reference

19 August 2017

Jacques Portoukalian

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

15 July 2008

1 reference

Biochimica et Biophysica Acta

19 August 2017

1 reference

19 August 2017

1795

1 reference

19 August 2017

1

1 reference

19 August 2017

16-24

1 reference

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

19 August 2017

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Killer dendritic cells: mechanisms of action and therapeutic implications for cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Structure, organization, and function of glycosphingolipids in membrane

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

A critical role for Stat3 signaling in immune tolerance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Links between innate and cognate tumor immunity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Natural killer or dendritic: what's in a name?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Immunosuppressive strategies that are mediated by tumor cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

IL-12 and IL-23: master regulators of innate and adaptive immunity.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cells: multi-lineal and multi-functional

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

A role for class A scavenger receptor in dendritic cell nibbling from live cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Angiogenesis and metastasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

[The JAK-STAT signaling pathway and its role in oncogenesis, immunomodulation and development].

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Negative regulation of cytokine signaling: STAT-induced STAT inhibitor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

CD28-mediated regulation of multiple myeloma cell proliferation and survival

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

The role of STATs in transcriptional control and their impact on cellular function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Lipid Composition of Human Malignant Melanoma Tumors at Various Levels of Malignant Growth

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

A novel dendritic cell subset involved in tumor immunosurveillance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Role of tumor-associated gangliosides in cancer progression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Tumor antigen presentation: changing the rules

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Balance between NF- B and JNK/AP-1 activity controls dendritic cell life and death

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

STAT-1 is activated by IL-4 and IL-13 in multiple cell types

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Plasmacytoid dendritic cells in immunity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Janus kinases: components of multiple signaling pathways

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

The role of dendritic cell precursors in tumour vasculogenesis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Expression of interleukin 10 in human melanoma.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

The dendritic cell system and its role in immunogenicity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Cancer immunoediting from immune surveillance to immune escape

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Role of cytokines in head and neck squamous cell carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2008.07.001

Identifiers

DOI

10.1016/J.BBCAN.2008.07.001

1 reference

19 August 2017

1 reference